Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. PTC Therapeutics's Total Inventories for the quarter that ended in Mar. 2022 was $15.6 Mil. PTC Therapeutics's Revenue for the
three
months ended in Mar. 2022 was $148.7 Mil.
PTC Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2022 was 0.11.
PTC Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2022
increased
from Dec. 2021 (0.10) to Dec. 2021 (0.11)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
PTC Therapeutics's Days Inventory for the
three
months ended in Mar. 2022 was 140.17.
Total Inventories can be measured by Days Sales of Inventory (DSI).
PTC Therapeutics's days sales of inventory (DSI) for the
three
months ended in Mar. 2022 was 9.55.
Inventory Turnover measures how fast the company turns over its inventory within a year.
PTC Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2022 was 0.65.
PTC Therapeutics Inventory-to-Revenue Historical Data
The historical data trend for PTC Therapeutics's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
PTC Therapeutics Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Inventory-to-Revenue
0.06
0.05
0.06
0.05
0.03
PTC Therapeutics Quarterly Data
Jun17
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Inventory-to-Revenue
0.15
0.14
0.12
0.10
0.11
Competitive Comparison
For the Biotechnology subindustry, PTC Therapeutics's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PTC Therapeutics Inventory-to-Revenue Distribution
For the Biotechnology industry and Healthcare sector, PTC Therapeutics's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where PTC Therapeutics's Inventory-to-Revenue falls into.
PTC Therapeutics Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PTC Therapeutics's Inventory-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
PTC Therapeutics's Days Inventory for the
three
months ended in Mar. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTC Therapeutics Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of PTC Therapeutics's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.11(0.27%) Volume: 957,080 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:PTCT has been successfully added to your 
